Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behet′s disease

Indian Journal of Dermatology

Volumn 55, Issue 3, 2010, Pages 215-220

  Hodeib, Abeer ^a   Elsharawy, Tarek ^a   Fawzi, Hisham ^b  

^a TANTA UNIVERSITY   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Behet's disease; endothelin 1; homocysteine; nitric oxide

Indexed keywords

ENDOTHELIN 1; HOMOCYSTEINE; NITRIC OXIDE;

ADULT; ARTERY THROMBOSIS; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MALE; MEDICAL HISTORY; RISK FACTOR; SUPERFICIAL THROMBOPHLEBITIS; VARICOSIS; VEIN THROMBOSIS;

EID: 77957742359     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.70667     Document Type: Article

References (31)

1. Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behet's disease: a pilot study. Clin Rheumatol 2005;24:324-30.
2. Yesudian PD, Edirisinghe DN, O'Mahony C. Behet's disease. Int J STD AIDS 2007;18: 221-7.
3. Karakucuk S, Baskol G, Oner AO, Baskol M, Mirza E, Ustdal M. Serum paraoxonase activity is decreased in the active stage of Behet's disease. Br J Ophthalmol 2004;88:1256-8.
4. Ulusoy RE, Karabudak O, Kilicaslan F, Kirilmaz A, Us MH, Cebeci BS. Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behet's disease. Rheumato Int 2008;28:617-21.
5. Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. J Inherit Metab Dis 2006;29:3-20.
6. Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, et al. Possible mechanisms of homocysteine toxicity. Kidney Int Suppl 2003;84:137-40.
7. Terashita K, Kato S, Sata M, Inoue S, Nakamura H, Tomoike H. Increased Endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis. Respirol 2006;11:145-51.
8. Kayikiolu M, Aksu K, Hasdemir C, Keser G, Turgan N, Kltrsay H, et al. Endothelial functions in Behet's disease. Rheumatol Int 2006;26:304-8.
9. Hamzaoui K, Chelbi H, Kamoun M, Ben Dhifallah I, Hamzaoui A. Increased Endothelin-1 levels of BAL fluid in patients with Behet's disease. Mediators Inflamm 2007;19:1-6.
10. Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S, et al. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behet's disease. Br J Dermatol 2005;153:526-30.
11. Wechsler B, Davatchi F, Hamza M. Criteria for diagnosis of Behet's disease-International Study Group for Behet's disease. Lancet 1990;335:1078-80.
12. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 1996; 268:142-51.
13. Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapiolu G,. Hyperhomocysteinaemia in Behet's disease. Rheumatol (Oxford) 2001;40:687-90.
14. Er H, Evereklioglu C, Cumurcu T, Trkz Y, Ozerol E, Sahin K, et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behet's disease. Br J Ophthalmol 2002;86:653-7.
15. Ate A, Aydintu O, Olmez U, Dzgn N, Duman M. Serum homocysteine level is higher in Behet's disease with vascular involvement. Rheumatol Int 2005;25:42-4.
16. Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simek B. Assessment of homocysteine, neopterin and nitricoxide levels in Behet's disease. Clin Chem Lab Med 2007;45:73-7.
17. Genest J Jr. Hyperhomocysteinemia-determining factors and treatment. Can J Cardiol 1999;15:35-8.
18. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 1996;126:1285-9.
19. Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, El Matri L, et al. Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behet's disease. Clin Chem Lab Med 2004;42:1417-23.
20. Ricart JM, Vay A, Todol J, Calvo J, Villa P, Estells A, et al. Thrombophilic risk factors and homocysteine levels in Behet's disease in eastern Spain and their association with thrombotic events. Thromb Haemost 2006; 95(4):618-24.
21. Eichinger S. Homocysteine, vitamin B6 and the risk of recurrent venous thromboembolism. Pathophysiol Haemost Thromb 2003;33:342.
22. Uslu T, Erem C, Tosun M, Deger O. Plasma endothelin-1 levels in Behet's disease. Clin Rheumatol 1997;16:59-61.
23. Ural AU, Yalcin A, Beyan C, Isimer A, Bayhan H. Plasma endothelin-1 concentrations in patients with Behet's disease. Scand J Rheumatol 1994;23:322-5.
24. Hamzaoui A, Hamzaoui K, Chabbou A, Ayed K. Endothelin-1 expression in serum and bronchoalveolar lavage from patients with active Behet's disease. Br J Rheumatol 1996; 35:357-8.
25. Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, et al. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 2003;106:129-36.
26. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behet's disease. Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S19-24.
27. Sancak B, Onder M, Oztas MO, Bukan N, Grer MA. Nitric oxide levels in Behet's disease. J Eur Acad Dermatol Venereol 2003;17:7-9.
28. Kandi B, Cicek D, Ilhan N. Vitamin levels in Behet's disease. J Dermatol Treat 2007; 18:69-75.
29. Aydin E, Sgt S, Ozyurt H, Ozugurlu F, Akyol O. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behet's disease with and without ocular disease. Ophthalmic Res 2004;36:177-82.
30. Orem A, Vanizor B, Cimit G, Kiran E, Deer O, Malko M. Decreased nitric oxide production in patients with Behet's disease. Dermatology 1999;198:33-6.
31. Russell AI, Lawson WA, Haskard DO. Potential new therapeutic options in Behet's syndrome. Biodrugs 2001;15:25-35.